Search

Your search keyword '"Lapucci A"' showing total 50 results

Search Constraints

Start Over You searched for: Author "Lapucci A" Remove constraint Author: "Lapucci A" Publisher springer science and business media llc Remove constraint Publisher: springer science and business media llc
50 results on '"Lapucci A"'

Search Results

5. A limited memory Quasi-Newton approach for multi-objective optimization

9. Impact of Natural Killer (NK) Cells on Immune Reconstitution, and Their Potential as a Biomarker of Disease Activity, in Alemtuzumab-Treated Patients with Relapsing Remitting Multiple Sclerosis: An Observational Study

10. An effective procedure for feature subset selection in logistic regression based on information criteria

11. Rapid, scalable assessment of SARS-CoV-2 cellular immunity by whole-blood PCR

13. Convergent Inexact Penalty Decomposition Methods for Cardinality-Constrained Problems

14. Neuromuscular complications following targeted therapy in cancer patients: beyond the immune checkpoint inhibitors. Case reports and review of the literature

15. An augmented Lagrangian algorithm for multi-objective optimization

16. Degree of microstructural changes within T1-SE versus T1-GE hypointense lesions in multiple sclerosis: relevance for the definition of 'black holes'

17. Impact of Natural Killer (NK) Cells on Immune Reconstitution, and Their Potential as a Biomarker of Disease Activity, in Alemtuzumab-Treated Patients with Relapsing Remitting Multiple Sclerosis: An Observational Study

19. Levels of Circulating mRNA for the Tenascin-X (TNXB) Gene in Maternal Plasma at the Second Trimester in Pregnancies with Isolated Congenital Ventricular Septal Defects

20. Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis

22. Circulating mRNA in Maternal Plasma at the Second Trimester of Pregnancy: A Possible Screening Tool for Cardiac Conotruncal and Left Ventricular Outflow Tract Abnormalities

23. Establishment and characterization of a new spontaneously immortalized ER−/PR−/HER2+ human breast cancer cell line, DHSF-BR16

26. Neuromuscular complications following targeted therapy in cancer patients: beyond the immune checkpoint inhibitors. Case reports and review of the literature

29. Degree of microstructural changes within T1-SE versus T1-GE hypointense lesions in multiple sclerosis: relevance for the definition of “black holes”

30. A longitudinal clinical and MRI evaluation of the treatment with erenumab

31. Synthesis and In Vivo Imaging of N-(3-[11C]Methoxybenzyl)-2-(3-Methoxyphenyl)ethylaniline as a Potential Targeting Agent for P-glycoprotein

34. Molecular imaging of multiple sclerosis: from the clinical demand to novel radiotracers

35. World Congress Integrative Medicine & Health 2017: part two

39. MILD: a laser altimeter transmitter for a Mercury planetary orbiter

41. World Congress Integrative Medicine & Health 2017: part two

42. Synthesis and In Vivo Imaging of N-(3-[11C]Methoxybenzyl)-2-(3-Methoxyphenyl)ethylaniline as a Potential Targeting Agent for P-glycoprotein

49. Apoptosis shifts to necrosis via intermediate types of cell death by a mechanism depending on c- myc and bcl-2 expression

Catalog

Books, media, physical & digital resources